tiprankstipranks
Advertisement
Advertisement
Oncology Platform Development Targets Hematologic and Solid Tumor Indications
PremiumPrivate CompaniesOncology Platform Development Targets Hematologic and Solid Tumor Indications
11d ago
Solu Therapeutics – Weekly Recap
Premium
Private Companies
Solu Therapeutics – Weekly Recap
21d ago
Solu Therapeutics Emphasizes Oncology Focus and CyTAC Platform in Cancer Prevention Context
Premium
Private Companies
Solu Therapeutics Emphasizes Oncology Focus and CyTAC Platform in Cancer Prevention Context
25d ago
Solu Therapeutics Showcases CyTAC Platform at AACR Partnering Event
PremiumPrivate CompaniesSolu Therapeutics Showcases CyTAC Platform at AACR Partnering Event
1M ago
Solu Therapeutics Highlights AACR Partnering Activity Around CyTAC Oncology Platform
Premium
Private Companies
Solu Therapeutics Highlights AACR Partnering Activity Around CyTAC Oncology Platform
1M ago
Solu Therapeutics Emphasizes Science-Driven Focus in Oncology and Immunology
Premium
Private Companies
Solu Therapeutics Emphasizes Science-Driven Focus in Oncology and Immunology
2M ago
Solu Therapeutics Emphasizes Mast Cell–Targeted Preclinical Immunology R&D
PremiumPrivate CompaniesSolu Therapeutics Emphasizes Mast Cell–Targeted Preclinical Immunology R&D
2M ago
Focus on Immunology Leadership Underscores Solu Therapeutics’ Scientific Orientation
Premium
Private Companies
Focus on Immunology Leadership Underscores Solu Therapeutics’ Scientific Orientation
2M ago
Solu Therapeutics Highlights Immunology Thought Leadership During Women’s History Month
Premium
Private Companies
Solu Therapeutics Highlights Immunology Thought Leadership During Women’s History Month
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100